Your browser doesn't support javascript.
loading
Prevención primaria y secundaria de muerte súibita en el ICD Registry Latin America / Primary and secondary prevention of sudden cardiac death in the icd registry-latin america
Ramos, José L; Muratore, Claudio; Pachón Mateos, José C; Rodríguez, Ángel; González Hermosillo, Antonio; Asenjo, René; Rodríguez D., Diego; Galvao, Silas; Duque, Mauricio; Escudero, Jaime; Reyes Caorsi, Walter; Cuvillier, Erick; Maloney, Jennifer.
Affiliation
  • Ramos, José L; Hospital Italiano. Rosario. AR
  • Muratore, Claudio; Medtronic Latinoamérica.
  • Pachón Mateos, José C; Hospital del Corazón. San Pablo. BR
  • Rodríguez, Ángel; VA Medical Center. San Juan. PR
  • González Hermosillo, Antonio; Instituto Nacional de Cardiología. MX
  • Asenjo, René; Clínica Alemana. Santiago. CL
  • Rodríguez D., Diego; Fundación Santa Fe. Bogotá. CO
  • Galvao, Silas; Beneficencia Portuguesa. San Pablo. BR
  • Duque, Mauricio; Clínica Medellín. Medellín. CO
  • Escudero, Jaime; Hospital Carlos Arévalo. Caracas. VE
  • Reyes Caorsi, Walter; Casa de Galicia. Montevideo. UY
  • Cuvillier, Erick; Medtronic Latinoamérica.
  • Maloney, Jennifer; Medtronic Latinoamérica.
Arch. cardiol. Méx ; Arch. cardiol. Méx;78(4): 400-416, Oct.-Dec. 2008.
Article ي Es | LILACS | ID: lil-565633
المكتبة المسؤولة: BR1.1
ABSTRACT
INTRODUCTION AND

OBJECTIVES:

The ICD Registry is an observational study conducted in Latin America to collect data on indications and follow-up care for primary or secondary prevention of sudden cardiac death patients. The objective of this study is to compare and evaluate the characteristics of primary versus secondary prevention in the patient population enrolled in the registry.

METHODS:

Demographic data, indication, etiology, NYHA functional class and left ventricular ejection fraction (LVEF), pharmacological treatment at implant and the type of ICD implanted were also collected. During the follow-up period the ICD therapies delivered, patient hospitalizations and mortality were evaluated.

RESULTS:

507 patients were evaluated. Average age 60 +/- 14 years old, 78% male. Coronary heart disease was the most common etiology (43.6%). NYHA Functional Class I/II at the time of implant (73.6%). Average LVEF was 34 +/- 16%. Out of 507 patients, 189 received an ICD for primary prevention; 318 for secondary prevention. Primary prevention patients were older, predominantly male and had a lower EF. The rate of mortality and hospitalizations were similar between both groups with a higher rate of appropriate therapies in secondary prevention patients.

CONCLUSIONS:

This is the first study to demonstrate clinical characteristics of primary prevention patients in Latin America. There were no significant statistically differences in a short follow-up period in mortality or hospitalization as compared to the secondary prevention patient population in the Registry.
الموضوعات
النص الكامل: 1 الفهرس: LILACS الموضوع الرئيسي: Death, Sudden, Cardiac نوع الدراسة: Clinical_trials / Observational_studies المحددات: Female / Humans / Male اللغة: Es مجلة: Arch. cardiol. Méx موضوع المجلة: CARDIOLOGIA السنة: 2008 نوع: Article
النص الكامل: 1 الفهرس: LILACS الموضوع الرئيسي: Death, Sudden, Cardiac نوع الدراسة: Clinical_trials / Observational_studies المحددات: Female / Humans / Male اللغة: Es مجلة: Arch. cardiol. Méx موضوع المجلة: CARDIOLOGIA السنة: 2008 نوع: Article